BioCentury
ARTICLE | Financial News

Neovacs completes rights offering

March 18, 2013 7:00 AM UTC

Neovacs S.A. (Euronext:ALNEV), Paris, France Business: Autoimmune, Inflammation, Cancer Date completed: 3/12/13 Type: Rights offering Raised: €7.2 million ($9.4 million) Shares: 4 million Price: €1.80...